(Q40461043)

20 September 2017

1 reference

title

Evolving role of theophylline for treatment of chronic childhood asthma. (English)

1 reference

20 September 2017

Szefler SJ

1

1 reference

20 September 2017

Bender BG

2

1 reference

20 September 2017

Jusko WJ

3

1 reference

20 September 2017

Lanier BQ

4

1 reference

20 September 2017

Lemanske RF Jr

5

1 reference

20 September 2017

Skoner DP

6

1 reference

20 September 2017

Stempel DA

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

The Journal of Pediatrics

20 September 2017

published in

1 reference

20 September 2017

volume

127

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

176-185

1 reference

A new approach to the treatment of asthma

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The assessment and treatment of asthma: a conference report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Management of asthma: a consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Asthma: a follow up statement from an international paediatric asthma consensus group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal Colle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Mucosal inflammation in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Damage of the airway epithelium and bronchial reactivity in patients with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The pathogenesis and significance of bronchial hyper-responsiveness in airways disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Cholinergic and neurogenic mechanisms in obstructive airways disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Neurogenic inflammation in the airways. I. Neurogenic stimulation induces plasma protein extravasation into the rat airway lumen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Partial inhibition of the early and late asthmatic response by a single dose of salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Comparison of orally administered metaproterenol and theophylline in the control of chronic asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The value of maintenance theophylline in steroid-dependent asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Rational Intravenous Doses of Theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline--an immunomodulatory role in asthma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The effect of theophylline and enprofylline on allergen-induced bronchoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Induction of suppressor T cells in asthmatic children by theophylline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline reduces pulmonary eosinophilia after various types of active anaphylactic shock in guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The relationship between airway inflammation and bronchial hyperresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Pharmacologic control of plasma exudation into tracheobronchial airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Comparison of human lung and intestinal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Histamine release in vitro: inhibition by catecholamines and methylxanthines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline and the immune response: in vitro and in vivo effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The effect of theophyllamine on T-lymphocyte activation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effect of theophylline and adenosine on eosinophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Pharmacology of upper airways challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effect of theophylline, terbutaline, and their combination on the immediate hypersensitivity skin-test reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Cyclic nucleotides and modulation of effector systems of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

The effects of theophylline on airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Diaphragmatic contractility enhanced by aminophylline: role of extracellular calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Clinical, physiologic, and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Effect of therapeutic plasma concentrations of theophylline on behavior, cognitive processing, and affect in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Does asthma or treatment with theophylline limit children's academic performance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Psychological change associated with theophylline treatment of asthmatic children: a 6-month study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline-induced behavior change in children. An objective evaluation of parents' perceptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline--how much is enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Theophylline metabolism during the first month of life and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Update on the pharmacodynamics and pharmacokinetics of theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Circadian variations in theophylline concentrations and the treatment of nocturnal asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Safety and efficacy of theophylline in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

Need for theophylline in severe steroid-requiring asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Theophylline-induced alterations in cellular immunity in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970292-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70292-X

1 reference

20 September 2017

1 reference